Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Right on, georgejjl. Many thanks to you for all of your great post. Best
Bourbon, we need to announce:
Announce a filing to seek "Rett and PDD" approval
and we will be over $50 in a flash! imo GL
Anavex 2-73. Break through drug in the CNS space. Sign me up for 50mg a day. Via home delivery.
georgejjl & XENA
Add me to the list
ANAVEX®2-73 treatment resulted in significant increase in the expression of the SIGMAR1 mRNA biomarker that significantly correlated with improvements in the primary and secondary clinical efficacy endpoints CoA (p = 0.029) and MDS-UPDRS Part III (p = 0.024) and MDS-UPDRS Total (p = 0.038)
14.51-point MDS-UPDRS (Movement Disorder Society- Unified Parkinson Disease Rating Scale) Total score improvement compared to placebo (p = 0.034)
Data strengthens regulatory pathway for Parkinson’s disease as new therapeutic target population for ANAVEX®2-73
AVXL, Leader in the CNS Biotech space!
georgejjl, I agree. Sign me up and make it 50mg for me please.
Via home delivery.
Correct, infitvest. They have been exposed.
https://insiderfinancial.com/reddit-rebellion-targeting-the-short-mafia-next/180939/
"The FDA is broken. It's controversial approval of an ineffective new Alzheimer's drug proves the agency puts profit over public health".
https://www.yahoo.com/news/fda-broken-controversial-approval-ineffective-120300323.html
Right on, Bourbon! Bring an extra bottle and I will pay you 10X that cost and drink it with you. Many Thanks for turning me on to AVXL. WooHoo. C'mon
This may need to be a 4 to 5 day celebration. That doesn't include traveling. Just block out a week. Lol.
We'll be dancing in the streets.
Agree, georgejjl. I would like to see us open at $75.00 per share where we should be trading and burn every body in between. C'mon.
I would like to see us open at $75.00 per share where we should be trading and burn every body in between. C'mon.
"Were taking care of business" "You might as well get used to me coming home a little late".
The Great AWB
WooHoo!, Amazing THINK AUTISM TREATMENT
Love it, georgejjl! C'mon.
Nidan7500 - We are finally in your famous flashover reality. Nice Call... BRAVO
Nidan7500 - We could be finally moving into the flashover reality that you often mention with AVXL cutting edge technology in the CNS space. Nice!
"The biomarker-driven clinical evidence is very exciting and opens the possibility of successful treatment for both adults and children with Rett syndrome and early interventions for modifying the course of the disease,” commented Walter E. Kaufmann, MD, Principal Investigator and Chief Medical Officer of Anavex. “The outcome of this trial is very promising in terms of both safety and clinical improvement. Despite the challenges of the older age of the cohort (patients were on average 24 years of age) and the relatively low dose (5 mg daily), ANAVEX®2-73 demonstrated clinically meaningful improvements in outcome measures evaluating multiple impairments, which are supported by correlations with objective biomarkers.”
Dr. Missling delivers.
WOW! Very Nice...
So I believe 2-73 does work in reducing epilepsy frequency in some girls. AVXL Needs to process data and report. You said, "So far the preliminary evidence is that it improves other aspects of a Rett girls life. That is good enough". I agree. imo. I am not a doctor.
Great video, georgejjl . Thanks
Xena - Interesting. Does Vanguard do this as well? If so, what can be done to stop it? TIA
Right! We want $1249.00 a share please.
Absolutely Unbelievable. Waiting for highly educated people to approve a drug that has over 6 years of documented proven safety and improvements in patients, in the CNS space. More than any other drug to date. Some have so many degrees they have lost count of their own temperature. How many deaths have happened that could have been prevented or extended. Unbelievable. imo
Wow! What a week. I believe "Anavex is the Great Awakening in the CNS biotech space". 2-73 has stellar results and reviews to date. All the makings of a new block buster drug. Not to mention 3-71. Dr. Missling is an absolute Hero. Common Australia approve 2-73 already. imo. GLTA
Also: Almost forgot. You can sign me up for A2-73 home delivery 50mg once per day 90 day supply for 1st year. via UPS, Fed Ex, US Mail of bicycle. Thanks
Nice call, Bourbon. New trading range $20-25
Best. 2x2
Right. I own them as well. Many thanks. AVXL to the moon. GLTU
Nice! Any other stock you like? You know how to pick them. Thanks
Guzzi62 - AMC and AVXL almost exact same chart pattern. GLTU
longtermbeliever - Is that you buying up all those shares to drive up the price? Lol. Just kidding. I believe we get RETT read outs tomorrow and we continue up. Hold on tight long. GLTU
TipRanks
3 “Strong Buy” Stocks With Robust Upside Ahead
Anavex Life Sciences (AVXL)
With the last stock we’re looking at here, we’re shifting our focus to the biotech industry. Anavex is a clinical-stage biopharmaceutical firm, developing treatments for ‘severe and devastating’ neurological diseases. The company’s lead drug candidate, Anavex2-73 (blarcamesine), is currently under investigation as a treatment for Rett syndrome, which has no available therapies, along with Alzheimer’s and Parkinson’s.
Anavex2-73 has several Phase 2/3 clinical trials underway simultaneously. The AVATAR and EXCELLENCE studies are evaluating the drug as a treatment for Rett syndrome, and a review of early safety results by the independent Data Safety Monitoring Board (DSMB) recommended that the studies continue without modification.
In regard to its Alzheimer’s studies, Anavex2-73 has shown to bring about an 8% improvement in activities of daily living by test patients.
While the late-stage clinical studies are making some waves for Anavex, the company has several additional research tracks, at earlier phases. Anavex2-73 is in preclinical and Phase 1 research for several additional conditions, including Fragile X syndrome. And the company has three additional drug candidates in preclinical research from conditions ranging from dementia to depression to stroke.
Soumit Roy, 5-star analyst with Jones Trading, takes an optimistic view of Anavex, based on the company’s early clinical results.
“Anavex has shown remarkable cognitive benefits at the longest duration observed amongst peers... We expect to see positive 12-month data from a randomized Phase 2b/3 trial in approx. 450 patients in mid-2022 and could see earlier data in 1Q22. Early data in Parkinson’s disease was encouraging— ‘2-73 improved core cognitive functions and significantly improved episodic memory in PD dementia patients,” Roy noted.
The analyst summed up, "We believe Anavex’s implied valuation barely includes opportunities in RTT and recent appreciation in stock price mostly came from broader interest in the Alzheimer’s disease space. With potentially two pivotal data in Rett in 3Q21, randomized data in Alzheimer’s disease in 1H22 & mid-2022, and pivotal trial initiation in Parkinson’s disease in 2H21, we are initiating coverage on Anavex’s stocks with a BUY rating..."
Along with that Buy rating, Roy sets a $35 price target that indicates ~74% share growth for the next year. (To watch Roy’s track record, click here)
Once again, we’re looking at a stock with a unanimous Strong Buy consensus rating, based on 3 recent positive reviews. AVXL shares have an average price target of $26.50, implying a 30% upside from the current share
https://finance.yahoo.com/news/3-strong-buy-stocks-robust-162449912.html
raja - Right! $0.23 cents per share. Lol, don't to be looked at as a cheap skate. Lol. Little after hours fun.
LMAO. George, I will give you $0.23 cents for all those shares. Bidding war already started. Lol.
Nice call Xena!
"Blue skies coming?"
Anavex - A2-73 Leader in the CNS biotech space. Stellar results and reviews to date. All the makings of a new block buster drug. Remember. No brain bleeding here. imo.
Easy justification with $20 billion MC increase. imo
Great information, George as always. Thanks
Right. That 25 billion MC Rico money courtesy of the FDA helped to make this cover up presentation. Very Nice. At the end, people still die but in a colorful expensive fashion. imo.
Unbelievable. BIIB got their approval and unbelievable 25 Billion MK pump.
What a racket. FDA passed a proven brain bleeding drug during drug trials and the company gained 25 billion market cap and paid off everyone that helped.
Now they have the capital to buy their competitors and don't even care to hide it. rico recardo. imo. Unbelievable.
Unbelievable. What a day. BIIB got their approval and unbelievable 25 Billion MK pump opening at $465 a share after the approval announcement. They traded for twenty minutes and were halted. Opened at $400 per share.
What a racket. FDA passed a proven brain bleeding drug during drug trials and the company gained 25 billion market cap on the open to pay everyone that helped off. imo
Now they have the capital to buy their competitors and don't even care to hide it. rico recardo. imo
Motley Fool Propaganda.
AVXL the Real WINNER coming next.
https://www.fool.com/investing/2021/06/07/forget-biogen-these-2-alzheimers-drug-stocks-could/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article
Exciting day here. Hopefully